Online, on-demand market research connecting you to the right healthcare stakeholders.
A new model of drugs has slowly been making its way into the U.S. healthcare market. It’s called “biosimilars” and it seeks to increase competition and potentially lower costs by mimicking brand-name biologic drugs derived from living organisms.
But key questions remain: Will savings materialize the way they have for chemical, synthetically produced generic drugs? Will physicians and patients want biosimilars substituted for their brand name cancer therapies – or will payors and insurance providers force the issue? How effective and equivalent to their biologic counterparts will biosimilars really be and will physicians adopt biosimilar prescribing behavior in large numbers?
The lack of real U.S. market data is making these questions center stage. In order to better understand how physicians feel about biosimilars entering the U.S. healthcare market, InCrowd used its microsurvey technology platform to tap into the thoughts of 150 board-certified physicians in therapeutic areas with high biologic use, including dermatology, endocrinology, gastroenterology, oncology, and rheumatology.
These microsurveys provide important insights into how doctors in target specialty groups understand major or minor developments in the industry.
Some of the significant findings from this survey include:
If you’re interested in obtaining a complimentary copy of the full InCrowd MicroSyndicated BioSimilars Report or any of our other proprietary MicroSyndicated Reports, please contact us at 617.934.1600 or send a request to firstname.lastname@example.org at your earliest convenience.
Additionally, InCrowd will be conducting a webinar, “The Future of Biosimilars,” on June 7, 2016, with various experts in the biosimilars space, including InCrowd’s co-founder and president, Diane Hayes, Ph.D. Register today!
We’d love to show you how physician answers are collected quickly, exceed traditional market research standards, and provide actionable insights.
Our sales team is standing by to help you customize the right program for your business.